We are live on ! Find out more
AHCO icon

AdaptHealth

219 hedge funds and large institutions have $1.29B invested in AdaptHealth in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 74 increasing their positions, 82 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.92% more ownership

Funds ownership: 98.34%101.27% (+2.9%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

10% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 82

3% less funds holding

Funds holding: 226219 (-7)

10% less capital invested

Capital invested by funds: $1.44B → $1.29B (-$149M)

13% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 32

41% less call options, than puts

Call options by funds: $40M | Put options by funds: $67.7M

Holders
219
Holders Change
-7
Holders Change %
-3.1%
% of All Funds
2.88%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
28
Increased
74
Reduced
82
Closed
32
Calls
$40M
Puts
$67.7M
Net Calls
-$27.7M
Net Calls Change
+$3.1M

AHCO Hedge Fund Activity: Q2 2025 in Review

219 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q2 2025, worth a combined $1.29B — down 10% from $1.44B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of AHCO and 28 opened new positions — a net loss of 4 holders — while 82 trimmed existing stakes and 74 added.

The largest buyer was Fidelity Investments, adding an estimated $20M. The largest seller was BlackRock, cutting an estimated $7.07M.

  • 219 institutional investors held AdaptHealth (AHCO) as of Q2 2025, down from 226 in Q1 2025.
  • Funds reported $1.29B of AdaptHealth stock for Q2 2025, down 10% quarter-over-quarter.
  • 28 funds opened new AdaptHealth positions in Q2 2025 and 32 closed out, a net change of -4 holders.
  • The largest AdaptHealth buyer in Q2 2025 was Fidelity Investments, an estimated $20M added.
  • The largest AdaptHealth seller in Q2 2025 was BlackRock, an estimated $7.07M sold.

Based on aggregated 13F filings for Q2 2025.